ClinicalTrials.gg
CompletedNCT04375241DETECT AFUpdated Jul 12, 2022

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

An observational study in Atrial Fibrillation, sponsored by Diagram B.V.. Completed at 1 site in Netherlands. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-12.

Sponsored by Diagram B.V. · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,168
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 255 studies in Atrial Fibrillation with a site in Netherlands — 33 open to participants now, 49 under way, 2 of them phase 3. Atrial Fibrillation · Netherlands.

Enrollment
11th of 63
2,168 · median 400
Started
2018
with 10 others
Observational
63 of 255
7 open now
Registered
177th of 255
by date

Among the 255 studies in Atrial Fibrillation with a site in Netherlands, this one is the 11th largest by enrollment of the 63 observational ones that give a count, is one of 11 that started in 2018, is one of 63 observational ones, and was the 177th registered.

Atrial Fibrillation

4,018 studies on the registry are indexed under Atrial Fibrillation; 965 are open to participants now.

Browse Atrial Fibrillation studies →

Open to participants now

33 of the 255 studies in Atrial Fibrillation with a site in Netherlands are open now. Recruiting first, the newest first:

28 more — sign in →

All 33 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 613 Atrial Fibrillation studies recruiting now, 410 (67%) set no upper age limit and 44 (7%) stop at 75 or younger; 21 take children under 18; 43 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 255 studies in Atrial Fibrillation with a site in Netherlands, or all of them as a file.
02

Study summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all.

The main objectives are:

  • To examine the feasibility of screening subjects of ≥65 years old for AAF.
  • To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.
Read the detailed description

Study design:

Prospective validation study.

03

Conditions studied

  • Atrial Fibrillation

Browse trials for

Keywords

  • Mobile ECG device
  • Asymptomatic atrial fibrillation
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The participants of this study will be subjects who visit their general practicioner or cardiologist or who visit the DETECT AF team at an event.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥65 years
  • Is willing to give

Exclusion criteria

Exclusion Criteria:

  • Known medical history with Atrial Fibrillation
  • Not mental competent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,168 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Screening with Mobile ECG Device

    Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

    Other: Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Interventions

  • OtherSubjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

    Subjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

06

What researchers measure

Primary outcomes

  1. Sensitivity of the mobile ECG device

    Time frame: At screening

  2. Specificity of the mobile ECG device

    Time frame: At screening

07

Study locations

1 site
  • Isala
    Zwolle, Overijssel 8025AB, Netherlands
08

References and documents

Individual participant data

Plan to share: Undecided — We have not yet decided to share the individual participant data.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2018 to primary completion in Apr 2021, 33 months.

Of 552 non-industry observational studies under Atrial Fibrillation, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 91. This study's 33 months is below that.

Counting every sponsor, half of 700 studies reached it within 38 months; a quarter within 22 and three quarters within 76.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2020
First posted
May 5, 2020
StartActual
Jul 2, 2018
Primary completionActual
Apr 30, 2021
CompletionActual
Apr 30, 2021
Last update
Jul 12, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 12, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04375241
Lead sponsor
Diagram B.V.
Responsible party
Sponsor
First posted
May 5, 2020
Start date
Jul 2, 2018
Primary completion
Apr 30, 2021
Completion
Apr 30, 2021
Last update
Jul 12, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion